Effects of Omega-3 Fatty Acids on Muscle Mass, Muscle Strength and Muscle Performance among the Elderly: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
There is increasing evidence showing the role of fatty acids and their derived lipid intermediates in the regulation of skeletal muscle mass synthesis and function. However, the role of omega-3 fatty acids remains unclear. Therefore, we conducted a meta-analysis to evaluate the potential effects of omega-3 fatty acids on sarcopenia-related performances among the elderly. Eligible literature and reports of randomized controlled trials were comprehensively searched from the PubMed, Cochrane Library, ClinicalTrials.gov, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases until July 2018. A total of 10 articles were available for the meta-analysis. There were minor benefits for muscle mass gain (0.33 kg; 95% CI: 0.05, 0.62) and timed up and go performance (−0.30 s; 95% CI: −0.43, −0.17). Subgroup analyses regarding muscle mass and walk speed indicated that omega-3 fatty acid supplements at more than 2 g/day may contribute to muscle mass gain (0.67 kg; 95% CI: 0.16, 1.18) and improve walking speed, especially for those receiving more than 6 months of intervention (1.78 m/sec; 95% CI: 1.38, 2.17). Our findings provide some insight into the effects of omega-3 fatty acids on muscle mass, especially for those taking supplements at more than 2 g/day. We also observed that a long period of omega-3 fatty acids supplementation may improve walking speed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In mice, acute administration raised circulating GLP-1 and insulin, improving glucose tolerance, an effect abrogated by a GLP-1 receptor antagonist (exendin-9), indicating an incretin-mediated hypoglycemic action [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In mice, acute administration raised circulating GLP-1 and insulin, improving glucose tolerance, an effect abrogated by a GLP-1 receptor antagonist (exendin-9), indicating an incretin-mediated hypoglycemic action [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
Experimental — accuracy not yet measuredIn the citing paper
“Taken together, evidence indicates that bitter melon could enhance the weight loss and glycemic benefits of GLP-1RAs by increasing endogenous GLP-1 and by improving metabolic profiles [193,194,198,199].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
In the citing paper
“In in vitro studies using the enteroendocrine cell line (STC-1), bitter melon extracts dosedependently increase GLP-1 release, an effect partially blocked by a bitter taste receptor antagonist (probenecid) and by a phospholipase Cβ2 inhibitor (U-73122), suggesting a taste receptor-mediated mechanism [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
In the citing paper
“In in vitro studies using the enteroendocrine cell line (STC-1), bitter melon extracts dosedependently increase GLP-1 release, an effect partially blocked by a bitter taste receptor antagonist (probenecid) and by a phospholipase Cβ2 inhibitor (U-73122), suggesting a taste receptor-mediated mechanism [193].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [193]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817 · cited 1×
“The methodological quality of included studies was evaluated according to the Cochrane Collaboration risk-of-bias tool [28].”
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · cited 1×
“This systematic review and meta-analysis was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [27].”
MethodSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 1×
“The recently updated consensus EWGSOP guideline for the case-finding and diagnosis of sarcopenia (EWGSOP2) focused on low muscle strength (and not low muscle mass) as a principal feature of sarcopenia [45].”
BackgroundSarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 2×
“The original definition of sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) was the “presence of both low muscle mass + low muscle function (strength or performance)” [3].”
BackgroundMethodGRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.006 · Cited by 10,578
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Meaningful change and responsiveness in common physical performance measures in older adults.
Perera, S., Mody, S. H., Woodman, R. C., & Studenski, S. A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00701.x · Cited by 2,513 · cited 1×
“This change is clinically relevant in the context of aging [49].”
BackgroundDisability in Older Adults: Evidence Regarding Significance, Etiology, and Risk
Fried, L. P., & Guralnik, J. M. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb00986.x · Cited by 866
Smith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005611 · Cited by 665 · cited 4×
“An association between n-3 PUFAs intake and musculoskeletal health has also been reported in RCTs [18,19], which showed that supplementation with n-3 PUFAs enhanced the rate of muscle protein synthesis in the elderly; in a strength-training trial [20], fish-oil supplementation resulted in significantly improved muscle…”
ResultInfluential
Cited by
Bird, J. K., Troesch, B., Warnke, I., & Calder, P. C. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.10.011 · Cited by 107
“Another meta-analysis using studies performed in elderly subjects identified that omega-3 LC PUFA supplements increased muscle mass, whereas grip strength was not affected [122].”
BackgroundResultAge-related muscle anabolic resistance: inevitable or preventable?
Aragon, A. A., Tipton, K. D., & Schoenfeld, B. J. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuac062 · Cited by 93
Cornish, S. M., Cordingley, D. M., Shaw, K. A., Forbes, S. C., Leonhardt, T., Bristol, A., Candow, D. G., & Chilibeck, P. D. (2022) · Nutrients · doi:10.3390/nu14112221 · Cited by 79
Advances in nutritional supplementation for sarcopenia management
Liu, S., Zhang, L., & Li, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1189522 · Cited by 75
The Effect of Omega-3 Fatty Acids on Sarcopenia: Mechanism of Action and Potential Efficacy
Therdyothin, A., Phiphopthatsanee, N., & Isanejad, M. (2023) · Marine Drugs · doi:10.3390/md21070399 · Cited by 93
“30 s respectively [46,59], although the latter was limited by the small number of pooled participants of only 73 receiving n-3 PUFA and 63 controls.”
BackgroundMethodInfluentialOrsso, C. E., Montes‐Ibarra, M., Findlay, M., van der Meij, B. S., de van der Schueren, M. A. E., Landi, F., Laviano, A., & Prado, C. M. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12954 · Cited by 73
Lin, H., Zhang, X., Liu, Y., Geng, L., Guan, L., & Li, X.-H. (2021) · Scientific Reports · doi:10.1038/s41598-021-89494-9 · Cited by 63
Tseng, P., Zeng, B., Zeng, B., Liao, Y., Stubbs, B., Kuo, J. S., Sun, C., Cheng, Y., Chen, Y., Chen, T., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102014 · Cited by 65
Jäger, R., Heileson, J. L., Abou Sawan, S., Dickerson, B. L., Leonard, M., Kreider, R. B., Kerksick, C. M., Cornish, S. M., Candow, D. G., Cordingley, D. M., et al. (2025) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2024.2441775 · Cited by 47
“Recent meta-analyses have reported positive effects on muscle function or strength [73,75,76,78], with or without resistance exercise training (RET), and one reported a significant increase in fat-free mass [73].”
Skeletal muscle dysfunction with advancing age
Pabla, P., Jones, E. J., Piasecki, M., & Phillips, B. E. (2024) · Clinical Science · doi:10.1042/cs20231197 · Cited by 55
“Indeed, relatively recent studies have shown that they can improve both SKM mass and strength in older people [220,221].”
BackgroundGagesch, M., Wieczorek, M., Vellas, B. J., Kressig, R. W., Rizzoli, R., Kanis, J., Willett, W. C., Egli, A., Lang, W., Orav, E. J., et al. (2022) · The Journal of Frailty & Aging · doi:10.14283/jfa.2022.48 · Cited by 49
Therdyothin, A., Prokopidis, K., Galli, F., Witard, O. C., & Isanejad, M. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae055 · Cited by 49
Livshits, G., & Kalinkovich, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102267 · Cited by 47
Sarcopenia and type 2 diabetes: Pathophysiology and potential therapeutic lifestyle interventions
Marcotte‐Chénard, A., Oliveira, B., Little, J. P., & Candow, D. G. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102835 · Cited by 47
The Asia–Oceania consensus: Definitions and diagnostic criteria for sarcopenic obesity
Chen, T., Kao, H., Ogawa, W., Arai, H., Tahapary, D. L., Assantachai, P., Tham, K. W., Chan, D., Yuen, M. M. A., Appannah, G., et al. (2025) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2025.05.001 · Cited by 47
Kunz, H., Michie, K. L., Gries, K. J., Zhang, X., Ryan, Z. C., & Lanza, I. R. (2022) · Nutrients · doi:10.3390/nu14173537 · Cited by 41
“A recent meta-analysis of the effects of n3-PUFA supplementation on muscle mass and strength in older adults reported consensus increases in muscle mass with a small to moderate effect size, but no consensus increases in muscle strength [62].”
BackgroundYang, Y. S., Pan, N., Luo, J., Liu, Y., & Ossowski, Z. M. (2025) · Nutrients · doi:10.3390/nu17142342 · Cited by 35
Zhou, Y., Zhou, L., Zhang, W., Chen, Y., She, K., Zhang, H., Gao, Y., & Yin, X. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1457187 · Cited by 33
Delaire, L., Courtay, A., Humblot, J., Aubertin‐Leheudre, M., Mourey, F., Racine, A. N., Gilbert, T., Niasse‐Sy, Z., & Bonnefoy, M. (2023) · Nutrients · doi:10.3390/nu15194100 · Cited by 36
“Similarly, supplementation with omega-3 fatty acids (with a daily intake of >2 g per day) may contribute to muscle mass gain, but evidence is poor and interactions with exercise remain unknown [305].”
BackgroundDiet and exercise in frailty and sarcopenia. Molecular aspects
Millan-Domingo, F., Garcia-Dominguez, E., Gambini, J., Olaso-Gonzalez, G., Viña, J., & Gomez-Cabrera, M. C. (2024) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2024.101322 · Cited by 31
Kim, D., Morikawa, S., Miyawaki, M., Nakagawa, T., Ogawa, S., & Kase, Y. (2025) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2025.05.005 · Cited by 32
“A meta-analysis [38] involving 552 individuals aged 65 – 75 years, the majority of whom were healthy older adults without sarcopenia, demonstrated that daily intake of ≥ 2 g of omega-3 fatty acids resulted in increased muscle mass (SMD = 0.67, P 0.05).”
InfluentialAndré, H. C. S., Esteves, G. P., Barreto, G., Longhini, F., Dolan, E., & Benatti, F. B. (2022) · Advances in Nutrition · doi:10.1016/j.advnut.2022.11.005 · Cited by 33
Navigating the Intersection: Sarcopenia and Sarcopenic Obesity in Inflammatory Bowel Disease
Calvez, V., Becherucci, G., Covello, C., Piccirilli, G., Mignini, I., Esposto, G., Laterza, L., Ainora, M. E., Scaldaferri, F., Gasbarrini, A., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12061218 · Cited by 32
Otsuka, Y., Iidaka, T., Horii, C., Muraki, S., Oka, H., Nakamura, K., Izumo, T., Rogi, T., Shibata, H., Tanaka, S., et al. (2021) · Nutrients · doi:10.3390/nu13051730 · Cited by 31
“However, the supplementation of specific fatty acids, such as omega-3 fatty acids, increases muscle mass and physical function in elderly people [47].”
BackgroundPegreffi, F., Chiaramonte, R., Zeppa, S. D., Lauretani, F., Salvi, M., Zucchini, I., Veronese, N., Vecchio, M. M., Bartolacci, A., Stocchi, V., et al. (2024) · Nutrients · doi:10.3390/nu16203462 · Cited by 28
“The study by Huang et al. proposes a supplement of 2 g/day of omega-3 fatty acids to obtain positive outcomes in sarcopenia-related performances among the elderly and underlined that a long period of omega-3 fatty acids supplementation may improve walking speed [79].”
BackgroundFat and fatty acids – a scoping review for Nordic Nutrition Recommendations 2023
Retterstøl, K., & Rosqvist, F. (2024) · Food & Nutrition Research · doi:10.29219/fnr.v68.9980 · Cited by 29
Gut dysmotility in children with neurological impairment: the nutritional management
Corsello, A., Scatigno, L., Govoni, A., Zuccotti, G., Gottrand, F., Romano, C., & Verduci, E. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1200101 · Cited by 28
Omega-3 polyunsatured fatty acids and physical performance across the lifespan: a narrative review
Azzolino, D., Bertoni, C., Cosmi, V. D., Spolidoro, G. C. I., Agostoni, C. V., Lucchi, T. A., & Mazzocchi, A. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1414132 · Cited by 28
Isanejad, M., Tajik, B., McArdle, A., Tuppurainen, M. T., Sirola, J. P., Kröger, H., Rikkonen, T., & Erkkilä, A. T. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02773-z · Cited by 30
Pérez-Castillo, Í. M., Rueda, R., Pereira, S. L., Bouzamondo, H., Chicharro, J. L., Segura-Ortiz, F., & Atherton, P. J. (2025) · Nutrients · doi:10.3390/nu17223503 · Cited by 28
“While uncertainties remain regarding the efficacy of n3-PUFA on improving muscle anabolism with aging, analyses of the literature suggest that these might provide benefits in terms of muscle mass and function in older individuals [194].”
Kalinkovich, A., & Livshits, G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102602 · Cited by 24
Taheri, M., Chilibeck, P. D., & Cornish, S. M. (2023) · Nutrients · doi:10.3390/nu15132926 · Cited by 27
“A recent meta-analysis has indicated that a longer (6-month) intervention is likely needed at a dose higher than 2 g/day to contribute to small muscle mass gain, strength increases, and functional improvements in older adults [68].”
BackgroundFatty Acids and Frailty: A Mendelian Randomization Study
Tomata, Y., Wang, Y., Hägg, S., & Jylhävä, J. (2021) · Nutrients · doi:10.3390/nu13103539 · Cited by 23
Self-citationTimraz, M., Binmahfoz, A., Quinn, T. J., Combet, E., & Gray, S. R. (2023) · Nutrients · doi:10.3390/nu15163579 · Cited by 24
“There has also been a systematic review and meta-analysis restricted to older people [18], which included studies with exercise training alongside LCn-3 PUFA supplementation, which found an increase in muscle mass but not strength.”
BackgroundResultInfluentialPérez-Piñero, S., Muñoz-Carrillo, J. C., Victoria‐Montesinos, D., García‐Muñoz, A. M., Andreu‐Caravaca, L., Gomez, M. F., Schölzel, M., García-Guillén, A. I., & López-Román, F. J. (2023) · Nutrients · doi:10.3390/nu15173848 · Cited by 21
“These findings align with benefits in TUG, muscle mass gain, and improved walking speed reported in a meta-analysis of 10 studies of omega-3 supplementation in elderly people [30].”
ResultEffects of Omega-3 fatty acids supplementation and resistance training on skeletal muscle
Uchida, Y., Tsuji, K., & Ochi, E. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.03.019 · Cited by 21
Zhang, Y., Guo, H., Liang, J., Xiao, W., & Li, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.738083 · Cited by 21
Baddela, V. S., Michaelis, M., Sharma, A., Plinski, C., Viergutz, T., & Vanselow, J. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102477 · Cited by 20
Omega-3 Fatty Acids and Muscle Strength—Current State of Knowledge and Future Perspectives
Tomczyk, M. (2024) · Nutrients · doi:10.3390/nu16234075 · Cited by 19
“In a meta-analysis including 10 randomized, controlled trials with a total of 552 participants aged 60 years and older, an increase in muscle strength was observed only with a dose higher than 2 g/day [59].”
Mocini, E., Piciocchi, C., Defeudis, G., & Migliaccio, S. (2025) · Gerontology · doi:10.1159/000546501 · Cited by 21
“Omega-3 fatty acids, found in fatty fish such as salmon and sardines, have been shown to reduce inflammation and improve muscle protein synthesis in older adults [33, 34].”
Zhang, Y., Liu, X., Ma, Y., & Li, X. (2023) · Nutrients · doi:10.3390/nu15153417 · Cited by 20
Zhou, Q., Lane, K. E., & Li, W. (2024) · Foods · doi:10.3390/foods13152407 · Cited by 18
“In the search for optimal health and wellbeing, long-chain omega-3 polyunsaturated fatty acids (LCn-3PUFA), specifically docosahexaenoic acid (DHA), mainly found in marine sources, have been extensively studied for their health benefits [1–6].”
BackgroundTailoring prehabilitation to address the multifactorial nature of functional capacity for surgery
Gillis, C., Coca-Martínez, M., & Mina, D. S. (2022) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.13050 · Cited by 22
Johnson, B. V. B., Milstead, M., Kreider, R., & Jones, R. (2025) · Obesity Pillars · doi:10.1016/j.obpill.2025.100209 · Cited by 27
“Theories suggest that omega-3 fatty acid supplementation supports muscle mass, muscle strength, and muscle performance through its anti-inflammatory pathways, promoting skeletal muscle protection [49].”
Nutritional Management Guidelines for Sarcopenia and Frailty 2025
Kuzuya, M., Kanno, Y., Arai, H., Nishiguchi, S., Iijima, K., Umegaki, H., Satake, S., Satô, S., Shinmura, K., Sugimoto, K., et al. (2025) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70275 · Cited by 20
Kim, Y., & Park, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1119719 · Cited by 17
Phillips, N., Gray, S. R., Combet, E., & Witard, O. C. (2023) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000986 · Cited by 17
Trends in Nutrition Research for Sarcopenia: A Bibliometric Analysis
Wu, L., He, K., Fang, D., Qiu, X., Xiao, W., Lou, S., & Yong, R.-L. (2022) · Nutrients · doi:10.3390/nu14204262 · Cited by 17
Bielecka-Dabrowa, A. M., Banach, M., Wittczak, A., Cicero, A. F. G., Kallel, A., Kubilius, R., Mikhailidis, D. P., Sahebkar, A., Stoian, A. P., Vinereanu, D., et al. (2023) · Archives of Medical Science · doi:10.5114/aoms/167799 · Cited by 20
Dietary patterns, metabolomics and frailty in a large cohort of 120 000 participants
Yao, Z., Jia, X., Chen, Z., Zhang, T., Li, X., Zhang, L., Chen, F., Zhang, J., Zhang, Z., Liu, Z., et al. (2024) · Food & Function · doi:10.1039/d3fo03575a · Cited by 16
Negri, M., Pivonello, C., Amatrudo, F., Cimmino, F., Trinchese, G., Vetrani, C., Iaccarino, G., Pivonello, R., Mollica, M. P., & Colao, A. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf007 · Cited by 17
Ahn, J., Kim, M., Won, C. W., & Park, Y. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1247594 · Cited by 15
Nutrition of aging people with diabetes mellitus: Focus on sarcopenia
Shalit, A., Gerontiti, E., Boutzios, G., Korakianiti, E., Kanouta, F., Vasileiou, V., Ψαλτοπούλου, Θ., & Paschou, S. Α. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.107975 · Cited by 16
Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19
Mayoral, L. P.-C., Matias‐Cervantes, C. A., Pérez‐Campos, E., Díaz, C. R., Barrios, L. Á. L., Pina-Canseco, M. D. S., Cruz, M. M., Mayoral, E. P., Solórzano-Mata, C. J., Canales, F. J. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158277 · Cited by 14
“Similarly, semaglutide and other antidiabetic drugs, as well as omega-3 fatty acids, are being evaluated for sarcopenia [99,100].”
BackgroundChou, S. H.-H., Cook, N. R., Kotler, G., Kim, E.-J., Copeland, T., Lee, I.-M. M., Cawthon, P. M., Buring, J. E., Manson, J. E., & LeBoff, M. S. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae150 · Cited by 14
Delpino, F. M., & Figueiredo, L. M. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.05.002 · Cited by 13
Zhang, Y., Zhang, P., Wang, F., & Xing, F. (2023) · European Geriatric Medicine · doi:10.1007/s41999-023-00822-w · Cited by 13
“In addition, n-3 fatty acids have the effect of reducing inflammatory response and protecting skeletal muscle and play an important role in the maintenance of muscle strength and function in the elderly [27].”
BackgroundSarcopenia in Rheumatic Diseases: A Hidden Issue of Concern
Pardali, E. C., Klonizakis, M., Goulis, D. G., Papadopoulou, S. Κ., Cholevas, C., Giaginis, C., Tsigalou, C., Bogdanos, D. P., & Grammatikopoulou, M. G. (2025) · Diseases · doi:10.3390/diseases13050134 · Cited by 16
“An increase in muscle mass gain and an improvement in walking speed has been observed in doses >2 g n-3 fatty acids/day for a duration of 6 months in older individuals [170].”
Increased Omega-3 Fatty Acid Intake Is Associated with Low Grip Strength in Elderly Korean Females
Bae, Y., Cui, X., & Shin, S. (2022) · Nutrients · doi:10.3390/nu14122374 · Cited by 13
Borazan, F. Y., Dazıroğlu, M. E. Ç., Gövez, N. E., Tek, N. A., & Varan, H. D. (2023) · Aging Clinical and Experimental Research · doi:10.1007/s40520-023-02599-1 · Cited by 12
“According to a large meta-analysis about the effect of n -3 PUFAs on muscle mass, long term n -3 PUFA supplementation may improve walking speed, muscle mass, and performance among older adults [37].”
Stuck, A. K., Molino, C. D. G. R. C., Freystaetter, G., Vellas, B. J., Kanis, J. А., Rizzoli, R., Kressig, R. W., Armbrecht, G., da Silva, J. A. P., Dawson-Hughes, B. F., et al. (2024) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19266 · Cited by 11
“14 Notably, the same meta-analysis suggested a potential dose-dependent effect, with more pronounced benefits at higher doses of 2 g/day.”
Stepaniak, U., Polak, M., Stefler, D., Kozela, M., Bobák, M., Niubo, A. S., Ayuso‐Mateos, J. L., Haro, J. M., & Pająk, A. (2022) · Nutrients · doi:10.3390/nu14122454 · Cited by 11
“Omega-3 PUFA have been suggested to have positive age-related effects on anabolic resistance and, therefore, enhance gains in muscle mass in older adults [18,50,51].”
BackgroundNunes, E. A., D'Souza, A. C., Steen, J. P., & Phillips, S. M. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.03.012 · Cited by 10
“Eleven studies contained a meta-analysis [19 e 21,24,26,32,38,39,46,48,50], and seven were systematic reviews [22,27,31,34,35,37,45].”
InfluentialImanian, B., Hemmatinafar, M., Maymandinejad, I., Binazade, M. R., Jäger, R., Jahan, Z., Naseri, K., Rezaei, R., & Suzuki, K. (2025) · Nutrients · doi:10.3390/nu17182959 · Cited by 10
“…examining 10 studies found moderate evidence supporting the positive effect of n -3 polyunsaturated fatty acids (PUFAs) on muscle mass, particularly when supplementation exceeds 2 g/day; EPA and DHA appear to play a modest yet effective role in preserving or enhancing muscle strength [9].”
Liu, S., Chen, Y., Tzeng, H.-P., & Chiang, M. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104755 · Cited by 12
d’Engremont, C., Grillot, J., Raillat, J., Vernerey, D., Vuitton, L., Koch, S., Turco, C., Heyd, B., Mouillet, G., Jacquinot, Q., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.683289 · Cited by 10
Watanabe, K., Holobar, A., Uchida, K., & Mita, Y. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.645747 · Cited by 12
Nieto, Á. A. V., Díaz, A. H., Millán, M. H., & Sagredo, D. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf201 · Cited by 12
Hamblen, A. J., Bray, J., Hingorani, M., & Saxton, J. (2023) · Proceedings of The Nutrition Society · doi:10.1017/s0029665123000046 · Cited by 9
He, C., Liu, W., Zhang, L., Chen, W., Liu, Z.-S., & Li, X. (2023) · Aquaculture Nutrition · doi:10.1155/2023/8347921 · Cited by 9
“When protein synthesis is greater than its catabolism, a tendency for muscle growth is usually observed [40].”
BackgroundFish Oil for Healthy Aging: Potential Application to Master Athletes
Murphy, C. H., & McGlory, C. (2021) · Sports Medicine · doi:10.1007/s40279-021-01509-7 · Cited by 11
Wang, Z., Zhu, Z., He, Z., Cheng, P., Liang, S., Chen, A., & Yang, Q. (2021) · Aging · doi:10.18632/aging.202655 · Cited by 9
Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review
Dias, D. D., Vasconcelos, A. R., Souza, A. C. R., Menezes, C. D., Silva, I. S. T. E., & Name, J. J. (2025) · Obesities · doi:10.3390/obesities5040088 · Cited by 8
“In older adults, >2 g/day was associated with modest gains in muscle mass (0.67 kg) and improvements in walking speed, particularly after interventions > 6 months (1.78 m/s; 95% CI: 1.38–2.17) [190].”
InfluentialYang, W.-C., Hsieh, H., Chen, J., Liu, L., & Chen, C. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03423-8 · Cited by 8
“Recent reports found that n-3 PUFA supplementation through a fish oil source enhanced muscle protein synthesis rates in older adults, improving muscle strength and boosting physical performance [32, 33].”
BackgroundMakaje, N., Ruangthai, R., & Sae‐tan, S. (2024) · Journal of Sports Science and Medicine · doi:10.52082/jssm.2024.317 · Cited by 8
“Omega-3 was reported that synergistically works with ingested protein in increasing protein utilization for muscle protein synthesis (Huang et al., 2020; Malta et al., 2019).”
BackgroundKhoonin, W., Shantavasinkul, P. C., Santivarangkna, C., Praengam, K., & Trachootham, D. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1164469 · Cited by 7
Li, Z., Yang, J., Yang, J., Liu, S., Guo, X., & Cui, Z. (2025) · Medicine · doi:10.1097/md.0000000000044312 · Cited by 7
“64] Therefore, in addition to advising adults to engage in PA and limit sedentary behavior, we should also recommend that adults consume 300 to 500g of vegetables and 200 to 350g of fruits daily, along with 1.0 to 1.2g of protein per kg of body weight, prioritizing high-quality sources like eggs,…”
InfluentialDam, D. L., Christensen, J. A., Olsen, P. Ø., Wilson, J. J., Tully, M. A., Buhl, S. F., & Caserotti, P. (2025) · Journal of Ageing and Longevity · doi:10.3390/jal5010004 · Cited by 8
Zhou, D., Liu, Y., Zhang, L., Lu, M., Gao, X., Li, G., Xiang, X., Xu, H., Li, G., Sun, Z., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067990 · Cited by 7
Kim, J.-E., Kim, M., Won, C. W., & Park, Y. S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1569832 · Cited by 6
Khalafi, M., Maleki, A. H., Symonds, M. E., Rosenkranz, S. K., Ehsanifar, M., & Dinani, S. M. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.01.022 · Cited by 6
Carpallo‐Porcar, B., Jiménez‐Sánchez, C., Calvo, S., Irún, P., Kolesnyk-Sumskaya, E., Blanco, A. I. A., & Beamonte, E. D. C. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321811 · Cited by 6
Potential benefits of nutritional supplementation in diabetic sarcopenia
Lee, H., Yang, S. J., & Lim, Y. (2022) · Redox Experimental Medicine · doi:10.1530/rem-22-0001 · Cited by 7
Rosqvist, F., Cedernaes, J., Mora, A. M., Fridén, M., Johansson, H.-E., Iggman, D., Larsson, A. O., Ahlström, H. K., Kullberg, J., & Risérus, U. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.04.010 · Cited by 5
Ghoreishy, S. M., Zeraattalab-Motlagh, S., Khosroshahi, R. A., Hemmati, A., Noormohammadi, M., & Mohammadi, H. (2024) · Clinical Nutrition Research · doi:10.7762/cnr.2024.13.3.186 · Cited by 5
“Omega-3 fatty acids increase muscle power and weight by reduction of the pro-inflammatory cytokines [7].”
BackgroundNutritional Considerations in Hip and Knee Arthroplasty: A Critical Analysis of Current Evidence
Arapovic, A. E., Nham, F. H., Darwiche, H. F., & El‐Othmani, M. M. (2024) · JBJS Reviews · doi:10.2106/jbjs.rvw.24.00033 · Cited by 5
Nutraceuticals: Health effects and clinical applications
Chen, O., & Mah, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821848-8.00043-3 · Cited by 5
Nyáry, D., Fekete, M., Ceglédi, A., Fazekas‐Pongor, V., Lipécz, Á., Csípő, T., Major, D., Péterfi, A., Csík, B., Zábó, V., et al. (2026) · Nutrients · doi:10.3390/nu18121920 · Cited by 7
“Evidence from randomized trials and meta-analyses evaluating omega-3 fatty acid supplementation indicates that these interventions primarily improve functional rather than structural outcomes [186].”
Diminished representation of vitamin-B12-producing bacteria in constipated elders with frailty
Zhao, L., Deng, X., Ding, N., Liu, Y., Ma, Y., Li, J., Wang, S., Ji, X., Wang, J., Wang, D., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110403 · Cited by 4
Palabıyık, A. A., & Palabıyık, E. (2025) · Nutrire · doi:10.1186/s41110-025-00381-z · Cited by 4
Takamori, S., Shimokawa, M., Yamaguchi, M., Mori, M., Kuyama, S., Oki, M., Nishimura, Y., Nakatomi, K., Yanai, H., Sukoh, N., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.70170 · Cited by 3
The Role of Omega-3 Polyunsaturated Fatty Acids on Sarcopenia and Aging Muscle
Varamini, B., Yang, J. O., Merry, B. J., & Dau, D. J. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23030355 · Cited by 3
“Meta-analyses have attempted to synthesize the heterogeneous literature on omega-3 and muscle mass. Huang et al. [50] analyzed 10 randomized controlled trials and found minor but significant benefits for muscle mass gain (0.33 kg; 95% CI: 0.05, 0.62) with omega-3 supplementation.”
InfluentialSołtysik, B. K., Balicki, P., Kowalczyk, K., Lutostańska, A., Dmuchowska, J., Pigłowska, M., & Kostka, T. (2025) · Nutrients · doi:10.3390/nu17111930 · Cited by 4
“A meta-analysis on omega-3 supplementation in older adults supports these findings, showing improved muscle strength and functional performance [43].”
Sarcopenia: Pathophysiology and Treatment Strategies
Qiu, C., Yang, X., & Yu, P. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230518105408 · Cited by 3
Fujibayashi, M., Nirengi, S., Segawa, T., Furuno, S., & Sakane, N. (2024) · Asian Journal of Sports Medicine · doi:10.5812/asjsm-134931 · Cited by 3
Doussat, C., Brioche, T., Casas, F., Capel, F., & Feillet‐Coudray, C. (2024) · OCL · doi:10.1051/ocl/2024011 · Cited by 5
“…the transcription factor NF-kappa B, involved in the regulation of immunity and in fl ammation, and notably in the increase in protein degradation in in fl ammatory states (Jeromson et al. , 2015) and it down-regulates proteasome expression involved in protein degradation (Huang et al. , 2020).”
BackgroundInfluentialYi, S., Kim, M., Won, C. W., & Park, Y. S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1543290 · Cited by 3
“A meta-analysis of clinical studies also showed that n-3 PUFA supplementation improved UGS in older Americans and Europeans (24).”
InfluentialNorooziseyedhosseini, H., Imani, R., Sumra, B., Tariq, M., & Upadhyay, M. (2023) · doi:10.22541/au.167655900.03369842/v1 · Cited by 3
Cordingley, D. M., Taheri, M., Fasihiyan, M., Woodmass, J. M., & Cornish, S. M. (2025) · Nutrients · doi:10.3390/nu17071273 · Cited by 3
“The current literature suggests that in older adult populations, a dose greater than 2 g/day of omega-3 fatty acids may be more beneficial to improve skeletal muscle mass than doses less than 2 g/day [74].”
Timraz, M., Guerrero‐Wyss, M., Quinn, T. J., Combet, E., Celis-Morales, C. A., & Gray, S. R. (2025) · The journal of nutrition health & aging · doi:10.1016/j.jnha.2025.100622 · Cited by 2
Metadata
- Authors
- Huang, Y.-H., Chiu, W.-C., Hsu, Y.-P., Lo, Y.-L., & Wang, Y.-H.
- Affiliations
- Taipei City Hospital (TW)
- Taipei Medical University (TW)
- Wan Fang Hospital (TW)
- National Yang Ming University (TW)
- Taipei Medical University-Shuang Ho Hospital (TW)
- Corresponding author
- Wang, Yuan-Hung
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-12-04
- Volume
- 12
- Issue
- 12
- Pages
- 3739
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7761957
- OpenAlex
- W3108657423
- Cited by
- 142
- References
- 50
- Citations by year
- 2026: 21 · 2025: 40 · 2024: 29 · 2023: 23 · 2022: 16 · 2021: 13
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- omega-3 fatty acids, dietary supplementation, sarcopenia, muscle mass, muscle strength, muscle performance, older adults, Timed Up and Go test, walking speed
- MeSH terms
- Physical Functional Performance, Aged, Diet, Docosahexaenoic Acids, Female, Gait, Humans, Male, Middle Aged, Eicosapentaenoic Acid, Fatty Acids, Omega-3, Randomized Controlled Trials as Topic, Muscle, Skeletal, Dietary Supplements, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.